Cellular factors involved in HTLV-1 entry and pathogenicity

Frontiers in Microbiology

Volumn 3, Issue JUN, 2012, Pages

  Hoshino, Hiroo ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cell tropism; Env isomerization; Env proteins; Epidemiology; Glucose transporter GLUT1; Heparan sulfate; Neuropilin 1; Syncytia formation

Indexed keywords

EID: 84874455753     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2012.00222     Document Type: Article

References (156)

1. Abe, M., Uchihashi, K., Kazuto, T., Osaka, A., Yanagihara, K., Tsukasaki, K., Hasegawa, H., Yamada, Y., and Kamihira, S. (2008). Foxp3 expression on normal and leukemic CD4+CD25+ T cells implicated in human T-cell leukemia virus type-1 is inconsistent with Treg cells. Eur. J. Haematol. 81,209-217.
2. Akagi, T., Takeda, I., Oka, T., Oht-suki, Y., Yano, S., and Miyoshi, I. (1985). Experimental infection of rabbits with human T-cell leukemia virus type 1. Jpn. J. Cancer Res. 76, 86-94.
3. Albrecht, B., Collins, N. D., Burniston, M. T., Nisbet, J. W., Ratner, L., Green, P. L., and Lairmore, M. D. (2000). Human T-lymphotropic virus type I open reading frame I p12(I) is required for efficient viral infectiv-ity in primary lymphocytes. J. Virol. 74,9828-9835.
4. Araujo, A., and Hall, W. W. (2004). Human T-lymphotropic virus type II and neurological disease. Ann. Neurol. 56, 10-19.
5. Arnold, J., Yamamoto, B., Li, M., Phipps, A. J., Younis, I., Lairmore, M. D., and Green, P. L. (2006). Enhancement of infectivity and persistence in vivo by HBZ, a natural antisense coded protein of HTLV-1. Blood 107, 3976-3982.
6. Asquith, B., Zhang, Y., Mosley, A. J., de Lara, C.M., Wallace, D. L., Worth, A., Kaftantzi, L., Meekings, K., Griffin, G. E., Tanaka, Y., Tough, D. F., Bev-erley, P. C., Taylor, G. P., Macallan, D. C., and Bangham, C. R. (2007). In vivo T lymphocyte dynamics in humans and the impact of human T lymphotropic virus 1 infection. Proc. Natl. Acad. Sci. U.S.A. 104, 8035-8040.
7. Baba, E., Nakamura, M., Tanaka, Y., Kuroki, M., Itoyama, Y., Nakano, S., and Niho, Y (1993). Multiple neutralizing B-cell epitopes of human T-cell leukemia virus type 1 (HTLV-1) identified by human monoclonal antibodies. A basis for the design of an HTLV-1 peptide vaccine. J. Immunol. 151, 1013-1024.
8. Barnard, R. J., Narayan, S., Dornadula, G., Miller, M. D., and Young, J. A. (2004). LowpHis required for avian sarcoma and leukosis virus Env-dependent viral penetration into the cytosol and not for viral uncoating. J. Virol. 78, 10433-10441.
9. Blattner, W A., Kalyanaraman, V S., Robert, G. M., Lister, T. A., Galton, D. A., Sarin, P. S., Crawford, M. H., Catovsky, D., Greaves, M., and Gallo, R. C. (1982). The human type-C retrovirus, HTLV, in Blacks from the Caribbean region, and relationship to adult T-cell leukemia/lymphoma. Int.J. Cancer 30,257-264.
10. Blot, V., Delamarre, L., Perugi, F., Pham, D., Benichou, S., Benarous, R., Hanada, T., Chishti, A. H., Dokhe-lar, M. C., and Pique, C. (2004). Human Dlg protein binds to the envelope glycoproteins of human T-cell leukemia virus type 1 and regulates envelope mediated cell-cell fusion in T lymphocytes. J. Cell Sci. 117,3983-3993.
11. Brighty, D. W., and Jassal, S. R. (2001). The synthetic peptide P-197 inhibits human T-cell leukemia virus type 1 envelope-mediated syncytium formation by a mechanism that is independent of Hsc70. J. Virol. 75, 10472-10478.
12. Cann, A. J., Rosenblatt, J. D., Wachs-man, W., Shah, N. P., and Chen, I. S. Y (1985). Identification of the gene responsible for human T-cell leukemia virus transcriptional regulation. Nature 318, 571-574.
13. Ceccaldi, P. E., Delebecque, F., Prevost, M. C., Moris, A., Abastado, J. P., Ges-sain, A., Schwartz, O., and Ozden, S. (2006). DC-SIGN facilitates fusion of dendritic cells with human T-cell leukemia virus type 1-infected cells. J. Virol. 80,4771-4780.
14. Chen, S., Ishii, N., Ine, S., Ikeda, S., Fujimura, T., Ndhlovu, L. C., Soroosh, P., Tada, K., Harigae, H., Kameoka, J., Kasai, N., Sasaki, T., and Sugamura, K. (2006). Regulatory T cell-like activity of Foxp3+ adult T cell leukemia cells. Int. Immunol. 18, 269-277.
15. Cho, I., Sugimoto, M., Mita, S., Toku-naga, M.,Imamura, F.,and Ando,M. (1995). In vivo proviral burden and viral RNA expression in T cell subsets of patients with human T lymphotropic virus type-1-associated myelopathy/tropical spastic para-paresis. Am. J. Trop. Med. Hyg. 53, 412-418.
16. Clap Ham, P., Nagy, K., Cheingsong, P. R., Exley, M., and Weiss, R. A. (1983). Productive infection and c ell-free transmission of human T-cell leukemia virus in a nonlymphoid cell line. Science 222, 1125-1127.
17. Coskun, A. K., and Sutton, R. E. (2005). Expression of glucose transporter 1 confers susceptibility to human T-cell leukemia virus envelope-mediated fusion. J. Virol. 79, 4150-4158.
18. Daenke, S., McCracken, S. A., and Booth, S. (1999). Human T-cell leukaemia/lymphoma virus type 1 syncytium formation is regulated in a cell-specific manner by ICAM-1, ICAM-3 and VCAM-1 and can be inhibited by antibodies to integrin beta2 or beta7. J. Gen. Virol. 80, 1429-1436.
19. Delamarre, L., Pique, C., Pham, D, Tursz, T., and Dokhelar, M. C. (1994). Identification of functional regions in the human T-cell leukemia virus type I SU glycoprotein.J. Virol. 68,3544-3549.
20. Delamarre, L., Rosenberg, A. R., Pique, C., Pham, D., Callebaut, I., and Dokhelar, M. C. (1996). The HTLV-I envelope glycoproteins: structure and functions. J. Acquir. Immune Defic. Syndr. Hum. Retrovi-rol. 13(Suppl. 1), S85-S91.
21. Derse, D., Hill, S. A., Lloyd, P. A., Chung, H. K., and Morse, B. A. (2001). Examining human T-lymphotropic virus type 1 infection and replication by cell-free infection with recom-binant virus vectors. J. Virol. 75, 8461-8468.
22. Desgranges, C., Souche, S., Vernant, J. C.,Smadja,D.,Vahlne,A., andHoral, P. (1994). Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera. AIDS Res. Hum. Retroviruses 10, 163-173.
23. Edlich, R. F., Arnette, J. A., and Williams, E M. (2000). Global epidemic of human T-cell lymphotropic virus type-I (HTLV-I). J. Emerg. Med. 18, 109-119.
24. Fan, N., Gavalchin, J., Paul, B., Wells, K. H., Lane, M. J., and Poiesz, B. J. (1992). Infection of peripheral blood mononuclear cells and cell lines by cell-free human T-cell lym-phoma/leukemia virus type I.J. Clin. Microbiol. 30, 905-910.
25. Fang, D., Haraguchi, Y., Jinno, A., Soda, Y., Shimizu, N., and Hoshino, H. (1999). Heat shock cognate protein 70 is a cell fusion-enhancing factor but not an entry factor for human T-cell lymphotropic virus type I. Biochem. Biophys. Res. Com-mun. 261,357-363.
26. Felber, B. K., Paskalis, H., Kleinman-Ewing, C., Wong-Staal, F., and Pavlakis, G. N. (1985). The pX protein of HTLV-I is a transcriptional activator of its long terminal repeats. Science 229, 675-679.
27. Feuer, G., and Green, P. L. (2005). Comparative biology of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2. Oncogene 24, 5996-6004.
28. Fujisawa, J., Seiki, M., Kiyokawa, T., and Yoshida, M. (1985). Functional activation of the long terminal repeat of human T-cell leukemia virus type I by a trans-acting factor. Proc. Natl. Acad. Sci. U.S.A. 82,2277-2281.
29. Fukushima, Y., Takahashi, H., Hall, W. W., Nakasone, T., Nakata, S., Song, P., Dinh Duc, D., Hien, B., Nguyen, X. Q., Ngoc Trinh, T., Nishioka, K., Kitamura, K., Komura, K., Vahlue, A., and Honda, M. (1995). Extraordinary high rate of HTLV type II seropositivity in intravenous drug abusers in South Vietnam. AIDS Res. Hum. Retroviruses 11, 637-645.
30. Gaudray, G., Gachon, F., Basbous, J., Biard-Piechaczyk, M., Devaux, C., and Mesnard, J. M. (2002). The complementary strand of the human T-cell leukemia virus type 1 RNA genome encodes a bZIP transcription factor that down-regulates viral transcription. J. Virol. 76, 12813-12822.
31. Gessain, A., Barin, F., Vernant, J. C., Gout, O., Maurs, L., Calender, A., and de The, G. (1985). Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 2, 407-410.
32. Gessain, A., Mahieux, R., and De, T. G. (1996). Genetic variability and molecular epidemiology of human and simian T cell leukemia/lymphoma virus type I. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 13, S132-S145.
33. Ghez, D., Lepelletier, Y., Jones, K. S., Pique, C., and Hermine, O. (2010). Current concepts regarding the HTLV-1 receptor complex. Retrovirology 7, 99.
34. Ghez, D., Lepelletier, Y., Lambert, S., Fourneau, J. M., Blot, V., Janvier, S., Arnulf, B., van Endert, P. M., Heveker, N., Pique, C., and Hermine, O. (2006). Neuropilin-1 is involved in human T-cell lymphotropic virus type 1 entry. J. Virol. 80, 6844-6854.
35. Goon, P. K., Hanon, E., Igakura, T., Tanaka, Y., Weber, J. N., Taylor, G. P., and Bangham, C. R. (2002). High frequencies of Th1-type CD4(+) T cells specific to HTLV-1 Env and Tax proteins in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis. Blood 99, 3335-3341.
36. Gotuzzo, E., Arango, C., deq Ueiroz-Campos,A.,and Isturiz,R.E. (2000). Human T-cell lymphotropic virus-I in Latin America. Infect. Dis. Clin. North Am. 14,211-239.
37. Hanon, E., Stinchcombe, J. C., Saito, M., Asquith, B. E., Taylor, G. P., Tanaka, Y., Weber, J. N., Griffiths, G. M., and Bangham, C. R. (2000a). Fratricide among CD8(+) T lymphocytes naturally infected with human T cell lymphotropic virus type I. Immunity 13, 657-664.
38. Hanon, E., Asquith, R. E., Taylor, G. P., Tanaka, Y., Weber, J. N., and Bangham, C. R. (2000b). High frequency of viral protein expression in human T cell lymphotropic virus type 1-infected peripheral blood mononuclear cells. AIDS Res. Hum. Retroviruses 16, 1711-1715.
39. Hattori, S., Kiyokawa, T., Imagawa, K., Shimizu, F., Hashimura, E., Seiki, M., and Yoshida, M. (1984). Identification of gag and env gene products of human T-cell leukemia virus (HTLV). Virology 136, 338-347.
40. Hieshima, K., Nagakubo, D., Nakayama, T., Shirakawa, A. K., Jin, Z., and Yoshie, O. (2008). Tax-inducible production of CC chemokine lig-and 22 by human T cell leukemia virus type 1 (HTLV-1)-infected T cells promotes preferential transmission of HTLV-1 to CCR4-expressing CD4+ T cells. J. Immunol. 180, 931-939.
41. Hildreth, J. E. (1998). Syncytium-inhibiting monoclonal antibodies produced against human T-cell lym-photropic virus type 1-infected cells recognize class II major histocom-patibility complex molecules and block by protein crowding. J. Virol. 72,9544-9552.
42. Hildreth, J. E., Subramanium, A., and Hampton, R. A. (1997). Human T-cell lymphotropic virus type 1 (HTLV-1)-induced syncytium formation mediated by vascular cell adhesion molecule-1: evidence for involvement of cell adhesion molecules in HTLV-1 biology. J. Virol. 71, 1173-1180.
43. Hino, S., Katamine, S., Kawase, K., Miyamoto, T., Doi, H., Tsuji, Y., and Yamabe, T. (1994). Intervention of maternal transmission of HTLV-1 in Nagasaki, Japan. Leukemia 8, S68-S70.
44. Hinuma, Y., Nagata, K., Hanaoka, M., Nakai, M., Matsumoto, T., Kinoshita, K.I., Shirakawa, S., and Miyoshi, I. (1981). Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc. Natl. Acad. Sci. U.S.A. 78, 6476-6480.
45. Hjelle, B., Appenzeller, O., Mills, R., Alexander, S., Torrez-Martinez, N., Jahnke, R., and Ross, G. (1992). Chronic neurodegenerative disease associated with HTLV-II infection. Lancet 339, 645-646.
46. Ho, D. D., Rota, T. R., and Hirsch, M. S. (1984). Infection of human endothelial cells by human T-lymphotropic virus type I. Proc. Natl. Acad. Sci. U.S.A. 81, 7588-7590.
47. Hoshino, H., Shimoyama, M., Miwa, M., and Sugimura, T. (1983). Detection of lymphocytes producing a human retrovirus associated with adult T-cell leukemia by syncytia induction assay. Proc. Natl. Acad. Sci. U.S.A. 80, 7337-7341.
48. Hoxie, J. A., Matthews, D. M., and Cines, D. B. (1984). Infection of human endothelial cells by human T-cell leukemia virus type I. Proc. Natl. Acad. Sci. U.S.A. 81, 7591-7595.
49. Ibrahim, J., Griffin, P., Coombe, D. R., Rider, C. C., and James, W. (1999). Cell-surface heparan sul-fate facilitates human immunodeficiency virus type 1 entry into some cell lines but not primary lymphocytes. Virus Res. 60, 159-169.
50. Igakura, T., Stinchcombe, J. C., Goon, P. K., Taylor, G. P., Weber, J. N., Griffiths, G. M., Tanaka, Y., Osame, M., and Bangham, C. R. M. (2003). Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton. Science 299, 1713-1716.
51. Ijichi, S., Ramundo, M. B., Takahashi, H., and Hall, W. W. (1992). In vivo cellular tropism of human T-cell leukemia virus type II (HTLV-II). J. Exp.Med. 176,293-296.
52. Jain, P., Manuel, S. L., Khan, Z. K., Ahuja, J., Quann, K., and Wigdahl, B. (2009). DC-SIGN mediates cell-free infection and transmission of human T-cell lymphotropic virus type 1 by dendritic cells. J. Virol. 83, 10908-10921.
53. Jassal, S. R., Pohler, R. G., and Brighty, D. W. (2001). Human T-cell leukemia virus type 1 receptor expression among syncytium-resistant cell lines revealed by a novel surface glycoprotein-immunoadhesin. J. Virol. 75, 8317-8328.
54. Jenkins, M. R., Tsun, A., Stinchcombe, J. C., and Griffiths, G. M. (2009). The strength of T cell receptor signal controls the polarization of cytotoxic machinery to the immuno-logical synapse. Immunity 31, 621-631.
55. Jin, Q., Agrawal, L., Van Horn-Ali, Z., and Alkhatib, G. (2006a). Infection of CD4+ T lymphocytes by the human T cell leukemia virus type 1 is mediated by the glucose transporter GLUT-1: evidence using antibodies specific to the receptors large extracellular domain. Virology 349, 184-196.
56. Jin, Q., Agrawal, L., Vanhorn-Ali, Z., and Alkhatib, G. (2006b). GLUT-1-independent infection of the glioblastoma/astroglioma U87 cells by the human T cell leukemia virus type 1. Virology 353, 99-110.
57. Jin, Q., Alkhatib, B., Cornetta, K., and Alkhatib, G. (2010). Alternate receptor usage of neuropilin-1 and glucose transporter protein 1 by the human T cell leukemia virus type 1. Virology 396, 203-212.
58. Jolly, C., and Sattentau, Q. J. (2005). Human immunodeficiency virus type 1 virological synapse formation in T cells requires lipid raft integrity. J. Virol. 79, 12088-12094.
59. Jones, K. S., Akel, S., Petrow-Sadowski, C., Huang, Y., Bertolette, D. C., and Ruscetti, F. W. (2005a). Induction of human T cell leukemia virus type I receptors on quiescent naive T lymphocytes by TGF-beta. J. Immunol. 174, 4262-4270.
60. Jones, K. S., Petrow-Sadowski, C., Bertolette, D. C., Huang, Y., and Ruscetti, E W. (2005b). Heparan sulfate pro-teoglycans mediate attachment and entry of human T-cell leukemia virus type 1 virions into CD4+ T cells. J. Virol. 79, 12692-12702.
61. Jones, K. S., Fugo, K., Petrow-Sadowski, C., Huang,Y., Bertolette, D. C., Lisin-ski, I., Cushman, S. W., Jacobson, S., and Ruscetti, F.W. (2006). Human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 use different receptor complexes to enter T cells. J. Virol. 80, 8291-8302.
62. Jones, K. S., Huang, Y K., Chevalier, S. A., Afonso, P. V., Petrow-Sadowski, C., Bertolette, D. C., Ges-sain, A., Ruscetti, E W., and Mahieux, R. (2009). The receptor complex associated with human T-cell lymphotropic virus type 3 (HTLV-3) Env-mediated binding and entry is distinct from, but overlaps with, the receptor complexes of HTLV-1 and HTLV-2. J. Virol. 83, 5244-5255.
63. Jones, K. S., Lambert, S., Bouttier, M., Bénit, L., Ruscetti, E W., Hermine, O., and Pique, C. (2011). Molecular aspects of HTLV-1 entry: functional domains of the HTLV-1 surface subunit (SU) and their relationships to the entry receptors. Viruses 3, 794-810.
64. Jones, K. S., Petrow-Sadowski, C., Huang, Y K., Bertolette, D. C., and Ruscetti, E W. (2008). Cell-free HTLV-1 infects dendritic cells leading to transmission and transformation of CD4(+)T cells. Nat Med. 14, 429-436.
65. Kajiyama, W., Kashiwagi, S., Ike-matsu, H., Hayashi, J., Nomura, H., and Okochi, K. (1986). Intrafa-milial transmission of adult T cell leukemia virus. J. Infect. Dis. 154, 851-857.
66. Kataoka, R., Takehara, N., Iwahara, Y., Sawada, T., Ohtsuki, Y., Dawei, Y., Hoshino, H., and Miyoshi, I. (1990). Transmission of HTLV-I by blood transfusion and its prevention by passive immunization in rabbits. Blood 76, 1657-1661.
67. Khabbaz, R. F., Onorato, I. M., Cannon, R. O., Hartley, T. M., Roberts, B., Hosein, B., and Kaplan, J. E. (1992). Seroprevalence of HTLV-1 and HTLV-2 among intravenous drug users and persons in clinics for sexually transmitted diseases. N Engl. J. Med. 326, 375-380.
68. Kim, E J., Manel, N., Garrido, E. N., Valle, C., Sitbon, M., and Battini, J. L. (2004). HTLV-1 and -2 envelope SU subdomains and critical determinants in receptor binding. Retrovirology 1, 41.
69. Kim, E J., Seiliez, I., Denesvre, C., Lav-illette, D., Cosset, F. L., and Sitbon, M. (2000). Definition of an amino-terminal domain of the human T-cell leukemia virus type 1 envelope surface unit that extends the fuso-genic range of an ecotropic murine leukemia virus. J. Biol Chem. 275, 23417-23420.
70. Kitajima, I., Yamamoto, K., Sato, K., Nakajima, Y., Nakajima, T., Maruyama, I., Osame, M., and Nish-ioka,K. (1991). Detection of human T cell lymphotropic virus type I proviral DNA and its gene expression in synovial cells in chronic inflammatory arthropathy. J. Clin. Invest. 88, 1315-1322.
71. Knight, S. C., Macatonia, S. E., Cruick-shank, K., Rudge, P., and Patterson, S. (1993). Dendritic cells in HIV-1 and HTLV-1 infection. Adv. Exp. Med. Biol. 329, 545-549.
72. Kobe, B., Center, R. J., Kemp, B. E., andPoumbourios,P. (1999). Crystal structure of human T cell leukemia virus type 1 gp21 ecto domain crystallized as a maltose-binding protein chimera reveals structural evolution of retroviral transmembrane proteins. Proc. Natl. Acad. Sci. U.S.A. 96, 4319-4324.
73. Koyanagi, Y., Itoyama, Y., Nakamura, N., Takamatsu, K., Kira, J., Iwa-masa, T., Goto, I., and Yamamoto, N. (1993). In vivo infection of human T-cell leukemia virus type I in non-T cells. Virology 196, 25-33.
74. Kuroki, M., Nakamura, M., Itoyama, Y., Tanaka, Y., Shiraki, H., Baba, E., Esaki, T., Tatsumoto, T., Nagafuchi, S., and Nakano, S. (1992). Identification of new epitopes recognized by human monoclonal antibodies with neutralizing and antibody-dependent cellular cytotoxicity activities specific for human T cell leukemia virus type 1. J. Immunol. 149, 940-948.
75. Kusuhara, K., Sunoda, S., Takahashi, K., Tokugawa, K., Fukushige, J., and Ueda, K. (1987). Mother to child transmission of human T cell leukemia virus type I (HTLV-I): a fifteen year followup study in Okinawa, Japan. Int. J. Cancer 40, 755-757.
76. Lairmore, M. D., Anupam, R., Bow-den, N., Haines, R., Haynes, R. A., Ratner, L., and Green, P. L. (2011). Molecular determinants of human T-lymphotropic virus type 1transmission and spread. Viruses 3, 1131-1165.
77. Lairmore, M. D., Silverman, L., and Rat-ner, L. (2005). Animal models for human T-lymphotropic virus type 1 (HTLV-1) infection and transformation. Oncogene 24, 6005-6015.
78. Lamb, D., Mirsaliotis, A., Kelly, S. M., and Brighty, D. W. (2009). Basic residues are critical to the activity of peptide inhibitors of human T cell leukemia virus type 1 entry. J. Biol. Chem. 284, 6575-6584.
79. Lambert, S., Bouttier, M., Vassy, R., Seigneuret, M., Petrow-Sadowski, C., Janvier, S., Heveker, N., Ruscetti, F. W., Perret, G., Jones, K. S., and Pique, C. (2009). HTLV-1 uses HSPG and neuropilin-1 for entry by molecular mimicry of VEGF165. Blood 113, 5176-5185.
80. Lavillette, D., Maurice, M., Roche, C., Russell, S. J., Sitbon, M., and Cosset, F.L. (1998). A proline-rich motif downstream of the receptor binding domain modulates conformation and fusogenicity of murine retroviral envelopes. J. Virol. 72, 9955-9965.
81. Lee, H., Swanson, P., Shorty, V. S., Zack, J. A., Rosenblatt, J. D., and Chen, I. S. Y. (1989). High rate of HTLVII infection in seropositive IV drug abusers from New Orleans. Science 244,471-475.
82. Lehky, T. J., Fox, C. H., Koenig, S., Levin, M. C., Flerlage, N., Izumo, S., Sato, E., Raine, C. S., Osame, M., and Jacobson, S. (1995). Detection of human T-lymphotropic virus type I (HTLV-I) tax RNA in the central nervous system of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by in situ hybridization. Ann. Neurol. 37, 167-175.
83. Li, K., Zhang, S., Kronqvist, M., Wallin, M., Ekstrom, M., Derse, D., and Garoff, H. (2008). Intersub-unit disulfide isomerization controls membrane fusion of human T-cell leukemia virus Env. J. Virol. 82, 7135-7143.
84. Londos-Gagliardi, D., Dalibart, R., Geoffre, S., Dalbon, P., Pouliquen, J. F., Georges-Courbot, M. C., Sainte-Foie, S., Hajjar, C., Georges, A. J., Moreau, J. P., and Guillemain, B. (1996). Immunogenicity of variable regions of the surface envelope gly-coprotein of HTLV type I and identification of new major epitopes in the 239-261 region. AIDS Res. Hum. Retroviruses 12, 941-950.
85. Macatonia, S. E., Cruickshank, J. K., Rudge, P., and Knight, S. C. (1992). Dendritic cells from patients with tropical spastic paraparesis are infected with HTLV-1 and stimulate autologous lymphocyte proliferation. AIDS Res. Hum. Retroviruses 8, 1699-1706.
86. Maerz, A. L., Center, R. J., Kemp, B. E., Kobe, B., and Poumbourios, P. (2000). Functional implications of the human T-lymphotropic virus type 1 transmembrane glycoprotein helical hairpin structure. J. Virol. 74, 6614-6621.
87. Mahieux, R., and Gessain, A. (2009). The human HTLV-3 and HTLV-4 retroviruses: new members of the HTLV family. Pathol. Biol. 57, 161-166.
88. Majorovits, E., Nejmeddine, M., Tanaka, Y., Taylor, G. P., Fuller, S. D., and Bangham, C. R. (2008). Human T-lymphotropic virus-1 visualized at the virological synapse by electron tomography. PLoS ONE 3, e2251. doi:10.1371/journal.pone.0002251
89. Manel, N., Battini, J. L., Taylor, N., and Sitbon,M. (2005a).HTLV-1 tropism and envelope receptor. Oncogene 24, 6016-6025.
90. Manel, N., Battini, J. L., and Sitbon, M. (2005b). Human T cell leukemia virus envelope binding and virus entry are mediated by distinct domains of the glucose transporter GLUT1. J. Biol. Chem. 280, 29025-29029.
91. Manel, N., Kinet, S., Battini, J. L., Kim, F. J.,Taylor,N., and Sitbon, M. (2003a). The HTLV receptor is an early T-cell activation marker whose expression requires de novo protein synthesis. Blood 101, 1913-1918.
92. Manel, N., Kim, F.J., Kinet, S., Taylor, N., Sitbon, M., and Battini, J. L. (2003b). The ubiquitous glucose transporter GLUT-1 is a receptor for HTLV. Cell 115,449-459.
93. Marsh, M., and Helenius, A. (2006). Virus entry: open sesame. Cell 124, 729-740.
94. Matsuoka, M., and Jeang, K. T. (2011). Human T-cell leukemia virus type 1 (HTLV-1) and leukemic transformation: viral infectivity, Tax, HBZ and therapy. Oncogene 30, 1379-1389.
95. Mazurov, D., Heidecker, G., and Derse, D. (2006). HTLV-1 Gag protein associates with CD82 tetraspanin microdomains at the plasma membrane. Virology 346, 194-204.
96. Mazurov, D., Ilinskaya, A., Heidecker, G., Lloyd, P., and Derse, D. (2010). Quantitative comparison of HTLV-1 and HIV-1 cell-to-cell infection with new replication dependent vectors. PLoS Pathog. 6, e1000788. doi:10.1371/journal.ppat. 1000788
97. Mirsaliotis, A., Lamb, D., and Brighty, D. W. (2008). Nonhelical leash and α-helical structures determine the potency of a peptide antagonist of human T-cell leukemia virus entry. J. Virol. 82, 4965-4973.
98. Mirsaliotis, A., Nurkiyanova, K., Lamb, D., Woof, J. M., and Brighty, D. W. (2007). Conformation-specific antibodies targeting the trimer-of-hairpins motif of the human T-cell leukemia virus type 1 transmembrane glycoprotein recognize the viral envelope but fail to neutralize viral entry. J. Virol. 81, 6019-6031.
99. Moriuchi, M., and Moriuchi, H. (2002). Transforming growth factor-beta enhances human T-cell leukemia virus type I infection. J. Med. Virol. 67, 427-430.
100. Mothes, W., Boerger, A. L., Narayan, S., Cunningham, J. M., and Young, J. A. (2000). Retroviral entry mediated by receptor priming and low pH triggering of an envelope glycoprotein. Cell 103, 679-689.
101. Murphy, E. L., Figueroa, J. P., Gibbs, W. N., Brathwaite, A., Holding, C. M., Waters, D., Cranston, B., Hanchard, B., and Blattner, W. A. (1989). Sexual transmission of human T-lymphotropic virus type I (HTLV-I). Ann. Intern. Med. 111, 555-560.
102. Nagai, M., Brennan, M. B., Sakai, J. A., Mora, C. A., and Jacobson, S. (2001). CD8(+) T cells are an in vivo reservoir for human T-cell lym-photropic virus type I. Blood 98, 1858-1861.
103. Nagy, K., Clapham, P., Cheingsong-Popov, R., and Weiss, R. A. (1983). Human T-cell leukemia virus type I: induction of syncytia and inhibition by patients sera. Int. J. Cancer 32, 321-328.
104. Nakamura, H., Hayami, M., Ohta, Y., Ishikawa, K., Tsujimoto, H., Kiyokawa, T., Yoshida, M., Sasagawa, A., and Honjo, S. (1987). Protection of cynomolgus monkeys against infection by human T-cell leukemia virus type-1 by immunization with viral env gene products produced in Escherichia coli. Int. J. Cancer 40, 403-407.
105. Nath, M. D., Ruscetti, F. W., Petrow-Sadowski, C., and Jones, K. S. (2003). Regulation of the cell-surface expression of an HTLV-I binding protein in human T cells during immune activation. Blood 101,3085-3092.
106. Nejmeddine, M., Barnard, A. L., Tanaka, Y., Taylor, G. P., and Bangham, C. R. M. (2005). Human T lymphotropic virus, type 1, tax protein triggers microtubule reorientation in the virological synapse. J. Biol. Chem. 280,29653-29660.
107. Nejmeddine, M., Negi, V S., Mukher-jee, S., Tanaka, Y., Orth, K., Taylor, G. P., and Bangham, C. R. M. (2009). HTLV-1-Tax and ICAM-1 act on T-cell signal pathways to polarize the microtubule-organizing center at the virological synapse. Blood 114, 1016-1025.
108. Nicot, C., Harrod, R. L., Ciminale, V., and Franchini, G. (2005). Human T-cell leukemia/lymphoma virus type 1 nonstructural genes and their functions. Oncogene 24, 6026-6034.
109. Okuma, K., Dalton, K. P., Buonocore, L., Ramsburg, E., Rose, J. K. (2003). Development of a novel surrogate virus for human T-cell leukemia virus type 1: inhibition of infection by osteoprotegerin. J. Virol. 77, 8562-8569.
110. Osame, M., and Igata, A. (1989). The history of discovery and clinico-epidemiology of HTLV-I-associated myelopathy (HAM). Jpn. J. Med. 28, 412-414.
111. Osame, M., Usuku, K., Izumo, S., Ijichi, N., Amitani, H., Igata, A., Matsumoto, M., and Tara, M. (1986). HTLV-I associated myelopathy, a new clinical entity. Lancet 1, 1031-1032.
112. Pais-Correia, A. M., Sachse, M., Guadagnini, S., Robbiati, V., Lasserre, R., Gessain, A., Gout, O., Alcover, A., and Thoulouze, M. I. (2009). Biofilm-like extracellular viral assemblies mediate HTLV-1 cell-to-cell transmission at virological synapses. Nat. Med. 16, 83-89.
113. Palker, T. J., Riggs, E. R., Spragion, D. E., Muir, A. J., Scearce, R. M., Randall, R. R., McAdams, M. W., McKnight, A., Clapham, P., and Weiss, R. A. (1992). Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins. J. Virol. 66, 5879-5889.
114. Pinon, J. D., Klasse, P. J., Jassal, S. R., Welson, S., Weber, J., Brighty, D. W., and Sattentau, Q. J. (2003a). Human T-cell leukemia virus type 1 envelope glycoprotein gp46 interacts with cell surface heparan sul-fate proteoglycans. J. Virol. 77, 9922-9930.
115. Pinon, J. D., Kelly, S. M., Price, N. C., Flanagan, J. U., and Brighty, D. W. (2003b). An antiviral peptide targets a coiled-coil domain of the human T-cell leukemia virus envelope glycoprotein. J. Virol. 77, 3281-3290.
116. Pinter, A., Kopelman, R., Li, Z., Kay-man, S. C., and Sanders, D. A. (1997). Localization of the labiledisulfide bond between SU and TM of the murine leukemia virus envelope protein complex to a highly conserved CWLC motif in SU that resembles the active-site sequence of thiol-disulfide exchange enzymes. J. Virol. 71,8073-8077.
117. Pique, C., Lagaudriere-Gesbert, C., Delamarre, L., Rosenberg, A. R., Conjeaud, H., and Dokhelar, M. C. (2000). Interaction of CD82 tetraspanin proteins with HTLV-1 envelope glycoproteins inhibits cell-to-cell fusion and virus transmission. Virology 276, 455-465.
118. Pique, C., Pham, D., Tursz, T., and Dokhelar, M. C. (1992). Human T-cell leukemia virus type I envelope protein maturation process: requirements for syncytium formation. J. Virol. 66,906-913.
119. Poiesz, B. J., Ruscetti, F. W., Gazdar, A. F., Bunn, P. A., Minna, J. D., and Gallo, R.C. (1980). Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lym-phoma. Proc. Natl. Acad. Sci. U.S.A. 77,7415-7419.
120. Proietti, F. A., Carneiro-Proietti, A. B., Catalan-Soares, B. C., and Murphy, E. L. (2005). Global epidemiology of HTLV-I infection and associated diseases. Oncogene 24, 6058-6068.
121. Richardson, J. H., Edwards, A. J., Cruickshank, J. K., Rudge, P., Dal-gleish, A. G. (1990). In vivo cellular tropism of human T-cell leukemia virus type 1. J. Virol. 64, 5682-5687.
122. Romeo, P. H., Lemarchandel, V., and Tordjman, R. (2002). Neuropilin-1 in the immune system. Adv. Exp. Med. Biol. 515, 49-54.
123. Sawada, T., Iwahara, Y., Ishii,K., Taguchi, H., Hoshino, H., and Miyoshi, I. (1991). Immunoglobulin prophylaxis against milkborne transmission of human T cell leukemia virus type 1 in rabbits. J. Infect. Dis. 164, 1193-1196.
124. Saxinger, W., Blattner, W. A., Levine, P. H., Clark, J., Biggar, R., Hoh, M., Moghissi, J., Jacobs, P., Wilson, L., Jacobson, R., Crookes, R., Strong, M., Angari, A. A., Dean, A. G., Nkrumah, E K., Mourali, N., and Gallo, R. C. (1984). Human T-cell leukemia virus (HTLV-I) antibodies in Africa. Science 225, 1473-1476.
125. Seiki, M., Hattori, S., Hirayama, Y., and Yoshida, M. (1983). Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA. Proc. Natl. Acad. Sci. U.S.A. 80, 3618-3622.
126. Setoyama, M., Kerdel, E A., Elgart, G., Kanzaki, T., and Byrnes, J. J. (1998). Detection of HTLV-1 bypolymerase chain reaction in situ hybridization in adult T-cell leukemia/lymphoma. Am. J. Pathol. 152, 683-689.
127. Shinagawa, M., Jinno-Oue, A., Shimizu, N., Roy, B. B., Shimizu, A., Hoque, S. A., and Hoshino, H. (2012). Human T-cell leukemia viruses are highly unstable over a wide range of temperatures. J. Gen. Virol. 93. 608-617.
128. Shintani, Y., Takashima, S., Asano, Y., Kato, H., Liao, Y., Yamazaki, S., Tsukamoto, O., Seguchi, O., Yamamoto, H., Fukushima, T., Suga-hara, K., Kitakaze, M., and Hori, M. (2006). Glycosaminoglycan modification of neuropilin-1 modulates VEGFR2 signaling. EMBO J. 25, 3045-3055.
129. Shukla, D., Liu, J., Blaiklock, P., Shworak, N. W., Bai, X., Esko, J. D., Cohen, G. H., Eisenberg, R. J., Rosenberg, R. D., and Spear, P. G. (1999). A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell 99, 13-22.
130. Silverman, L. R., Phipps, A. J., Montgomery, A., Ratner, L., and Lair-more, M. D. (2004). Human T-cell lymphotropic virus type 1 open reading frame II-encoded p30II is required for in vivo replication: evidence of in vivo reversion. J. Virol. 78, 3837-3845.
131. Sodroski, J. G., Rosen, C. A., and Hasel-tine, W. A. (1984). Trans-acting tran-scriptional activation of the long terminal repeat of human T lymphotropic viruses in infected cells. Science 223, 381-385.
132. Soker, S., Takashima, S., Miao, H. Q., Neufeld, G., and Klagsbrun, M. (1998). Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92, 735-745.
133. Sonoda, S., Li, H. C., and Tajima, K. (2011). Ethnoepidemiology of HTLV-1 related diseases: ethnic determinants of HTLV-1 susceptibility and its worldwide dispersal. Cancer Sci. 102, 295-301.
134. Sutton, R. E., and Littman, D. R. (1996). Broad host range of human T-cell leukemia virus type 1 demonstrated with an improved pseudotyping system. J. Virol. 70, 7322-7326.
135. Suzuki, M., Matsuoka, H., Yamashita, K., Maeda, K., Kawano, K., Uno, H., and Tsubouchi, H. (1998). CD45RO expression on peripheral lymphocytes as a prognostic marker for adult T-cell leukemia. Leuk. Lym-phoma 28, 583-590.
136. Takatsuki, K. (2005). Discovery of adult T-cell leukemia. Retrovirology 2, 16.
137. Tanaka, A., Jinno-Oue, A., Shimizu, N., Hoque, A., Mori, T., Islam, S., Nakatani, Y., Shinagawa, M., and Hoshino, H. (2012). Entry of human T-cell leukemia virus type 1 is augmented by heparan sulfate proteo-glycans bearing short heparin-like structures. J. Virol. 86, 2959-2969.
138. Tanaka, Y., Fukudome, K., Hayashi, M., Takagi, S., and Yoshie, O. (1995). Induction of ICAM-1 and LFA-3 by Tax1 of human T-cell leukemia virus type 1 and mechanism of down-regulation of ICAM-1 or LFA-1 in adult T cell leukemia cell lines. Int. J. Cancer 60, 554-561.
139. Tanaka, Y., Tanaka, R., Terada, E., Koyanagi, Y., Miyanokurosaki, N., Yamamoto, N., Baba, E., Nakamura, M., and Shida, H. (1994). Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization. J. Virol. 68, 6323-6331.
140. Tanaka, Y., Zeng, L., Shiraki, H., Shida, H., and Tozawa, H. (1991). Identification of a neutralization epitope on the envelope gp46 antigen of human T-cell leukemia virus type I and induction of neutralizing antibody by peptide immunization. J. Immunol. 147, 354-360.
141. Tordjman, R., Lepelletier, Y., Lemarchandel, V., Cambot, M., Gaulard, P., Hermine, O., and Romeo, P. H. (2002). A neuronal receptor, neuropilin-1, is essential for the initiation of the primary immune response. Nat. Immunol. 3, 477-482.
142. Toulza, F., Nosaka, K., Takiguchi, M., Pagliuca, T., Mitsuya, H., Tanaka, Y., Taylor, G. P., and Bangham, C. R. (2009). FoxP3+ regulatory T cells are distinct from leukemia cells in HTLV-1-associated adult T-cell leukemia. Int. J. Cancer 125, 2375-2382.
143. Trejo, S. R., and Ratner, L. (2000). The HTLV receptor is a widely expressed protein. Virology 268, 41-48.
144. Uchiyama, T. (1997). Human T cell leukemia virus type I (HTLV-I) and human diseases. Annu. Rev. Immunol. 15, 15-37.
145. Uemura, Y., Kotani, S., Yoshimoto, S., Fujishita, M., Yamashita, M., Oht-suki, Y., Taguchi, H., and Miyoshi, I. (1987). Mother-to-offspring transmission of human T cell leukemia virus type I in rabbits. Blood 69, 1255-1258.
146. Ureta-Vidal, A., Angelin-Duclos, C., Tortevoye, P., Murphy, E., Lepere, J. F., Buigues, R. P., Jolly, N., Jou-bert, M., Carles, G., Pouliquen, J. F., de The, G., Moreau, J. P., and Gessain, A. (1999). Mother-to-child transmission of human T-cell-leukemia/lymphoma virus type I: implication of high antiviral antibody titer and high proviral load in carrier mothers. Int. J. Cancer 82, 832-836.
147. van Prooyen, N., Gold, H., Andresen, V., Schwartz, O., Jones, K., Ruscetti, E, Lockett, S., Gudla, P., Ven-zon, D., and Franchini, G. (2010). Human T-cell leukemia virus type 1 p8 protein increases cellular conduits and virus transmission. Proc. Natl. Acad. Sci. U.S.A. 107, 20738-20743.
148. Wallin, M., Ekstrom, M., and Garoff, H. (2004). Isomerization of the inter-subunit disulphide-bond in Env controls retrovirus fusion. EMBO J. 23, 54-65.
149. Walter, M. J., Lehky, T. J., Fox, C. H., and Jacobson, S. (1994). In situ PCR for the detection of HTLV-I in HAM/TSP patients. Ann. N. Y. Acad. Sci. 724, 404-413.
150. Wielgosz, M. M., Rauch, D. A., Jones, K. S., Ruscetti, E W., and Ratner, L. (2005). Cholesterol dependence of HTLV-I infection. AIDS Res. Hum. Retroviruses 21, 43-50.
151. Wilson, K. A., Bär, S., Maerz, A. L., Alizon, M., and Poumbourios, P. (2005). The conserved glycine-rich segment linking the N-terminal fusion peptide to the coiled coil of human T-cell leukemia virus type 1 transmembrane glycoprotein gp21 is a determinant of membrane fusion function. J. Virol. 79, 4533-4539.
152. Wucherpfennig, K. W., Hollsberg, P., Richardson, J. H., Benjamin, D., and Hafler, D. A. (1992). T-cell activation by autologous human T-cell leukemia virus type I-infected T-cell clones. Proc. Natl. Acad. Sci. U.S.A. 89,2110-2114.
153. Yanagihara, R., Jenkins, C. L., Alexander, S. S., Mora, C. A., and Gar-ruto, R. M. (1990). Human T lymphotropic virus type I infection in Papua New Guinea: high prevalence among the Hagahai confirmed by western analysis. J. Infect. Dis. 162, 649-654.
154. Yano, H., Ishida, T., Inagaki, A., Ishii, T., Kusumoto, S., Komatsu, H., Iida, S., Utsunomiya, A., and Ueda, R. (2007). Regulatory T-cell function of adult T-cell leukemia/lymphomacells. Int. J. Cancer 120, 2052-2057.
155. Yoshida, M., Miyoshi, I., and Hinuma, Y. (1982). Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc. Natl. Acad. Sci. U.S.A. 79, 2031-2035.
156. Yoshikura, H., Nishida, J., Yoshida, M., Kitamura, Y., Takaku, F., and Ikeda, S. (1984). Isolation of HTLV derived from Japanese adult T-cell leukemia patients in human diploid fibrob-last strain IMR90 and the biological characters of the infected cells. Int. J. Cancer 33, 745-749.